New Delhi: India will not buy Pfizing/BioNTech and Moderna shots from COVID-19, according to three government sources, mainly as domestic output of easier and more affordable vaccines is increasing. This…
Latest News
-
-
Uncategorized
India’s mega vaccination efforts to gain significant momentum from the first Johnson and Johnson doses in October
New Delhi: New Delhi Sources have revealed that India could receive its initial dose of Johnson & Johnson Jab in October as a major boost to Prime Minister Narendra Modi’s…
-
The Phase 2 and 3 clinical trials for Coronavirus vaccine (covaxin) for age 2 to 18 years have been completed by Hyderabad based Bharat Biotech. Data are expected to be…
-
Uncategorized
If NEET continues in just a few years, it may be not sufficient to employ expert physicians in government hospitals:Report
If the medical entrance examination — NEET — continues, there may not be enough expert doctors to be used at government hospitals, 165 pages of a report on medical admissions…
-
Vidushi Chitalia, thirty-year-old research scientist, loads a cartridge to a large screen sequencing machine. The card contains everything needed for the sequence of genomes — 20 microliters of barcoded genetic…
-
Uncategorized
Study suggests association of Lung Hyperinflation With Coronary Artery Disease In Smokers
In smokers, including those with airflow restriction, a recent study revealed a robust link between lung hyperinflation and clinical and subclinical coronary artery disease (CAD). After accounting for lung hyperinflation,…